<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 16 )*
------
Abbott Laboratories
----------------------------------
(Name of Issuer)
Common shares without par value
----------------------------------
(Title of Class of Securities)
002824 10 0
----------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement / /. (A
fee is not required only if the filing person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
(Continued on following page(s))
Page 1 of 7 Pages
---
<PAGE>
CUSIP No. 002824 10 0 13G Page 2 of 7 Pages
----------- --- ---
- -------------------------------------------------------------------------------
(1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above
Persons
Abbott Laboratories Stock Retirement Trust
I.R.S. Identification No. 36-6047554
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) /x/
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
Illinois
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting
Beneficially Power 0
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting
Person With Power 65,483,967
--------------------------------------------------
(7) Sole Dispositive
Power 0
--------------------------------------------------
(8) Shared Dispositive
Power 65,483,967
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
65,483,967
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
/X/
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
8.2%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
EP
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 002824 10 0 13G Page 3 of 7 Pages
----------- --- ---
- -------------------------------------------------------------------------------
(1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above
Persons
Gary P. Coughlan
###-##-####
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) /x/
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
United States
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting 74,916 shares - direct
Beneficially Power (Does not include shares held in
Owned by the Abbott Laboratories Stock
Each Reporting Retirement Trust for the benefit
Person With of the reporting person.)
--------------------------------------------------
(6) Shared Voting 65,483,967 - shares as Trustee,
Power Abbott Laboratories Stock
Retirement Trust.
1,085,640 - as Director, Abbott
Laboratories Fund.
--------------------------------------------------
(7) Sole Dispositive 74,916 shares direct
Power (see note in 5 above)
--------------------------------------------------
(8) Shared Dispositive 65,483,967 as Trustee,
Power Abbott Laboratories Stock
Retirement Trust.
1,085,640 as Director,
Abbott Laboratories Fund.
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
66,751,633 (Total of 5 + 6 + 107,110 shares - right to acquire by exercise
of stock options.)
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
8.3%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 002824 10 0 13G Page 4 of 7 Pages
----------- --- ---
- -------------------------------------------------------------------------------
(1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above
Persons
Thomas C. Freyman
###-##-####
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) /x/
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
United States
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting 21,258 shares direct
Beneficially Power (Does not include shares held in
Owned by the Abbott Laboratories Stock
Each Reporting Retirement Trust for the benefit
Person With of the reporting person.)
--------------------------------------------------
(6) Shared Voting 65,483,967 as Trustee Abbott
Power Laboratories Stock Retirement
Trust.
--------------------------------------------------
(7) Sole Dispositive 21,258 shares
Power (See note 5 above)
--------------------------------------------------
(8) Shared Dispositive 65,483,967 as Trustee,
Power Abbott Laboratories Stock
Retirement Trust.
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
65,526,593 (total of 5 + 6 + 21,368 shares - right to acquire by exercise
of stock options.)
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
8.2%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 002824 10 0 13G Page 5 of 7 Pages
----------- --- ---
- -------------------------------------------------------------------------------
(1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above
Persons
Ellen M. Walvoord
###-##-####
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) /x/
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
United States
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting 19,000 shares direct
Beneficially Power (Does no include shares held in
Owned by the Abbott Laboratories Stock
Each Reporting Retirement Trust for the benefit
Person With of the reporting person.)
--------------------------------------------------
(6) Shared Voting 65,483,967 shares as Trustee,
Power Abbott Laboratories Stock
Retirement Trust.
--------------------------------------------------
(7) Sole Dispositive 19,000
Power (See note in 5 above.)
--------------------------------------------------
(8) Shared Dispositive 65,483,967 as Trustee,
Power Abbott Laboratories Stock
Retirement Trust.
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
65,535,321 (Total of 5 + 6 + 32,354 shares - right to acquire by exercise
of stock options.)
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
8.2%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
Item 1(a) Name of Issuer:
Abbott Laboratories
Item 1(b) Address of Issuer's Principal Executive Offices:
100 Abbott Park Road
Abbott Park, Illinois 60064-3500
Item 2(a) Name of Persons Filing:
Abbott Laboratories Stock Retirement Trust
Gary P. Coughlan
Thomas C. Freyman
Ellen M. Walvoord
Item 2(b) Address of Principal Business Office:
100 Abbott Park Road
Abbott Park, Illinois 60064-3500
Item 2(c) Citizenship:
Abbott Laboratories Stock Retirement Trust - Illinois.
Gary P. Coughlan, Thomas C. Freyman, and
Ellen M. Walvoord - United States
Item 2(d) Title of Class of Securities:
Common shares without par value
Item 2(e) CUSIP Number:
002824 10 0
Item 3. If this statement is filed pursuant to Rules 13d-1(b) or
13d-2(b), check whether the person filing is an:
[X] Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act
of 1974.
Item 4. Ownership
(a) (See cover pages 2, 3,
(b) 4 and 5, Items 5 through
(c) 9 and 11.)
Item 5. Ownership of Five Percent or Less of a Class
Not applicable.
Page 6 of 7 pages
<PAGE>
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
The shares owned by the Abbott Laboratories Stock Retirement
Trust and the dividends thereon are held for the benefit of
participants of the Abbott Laboratories Stock Retirement Plan
pursuant to terms of that Plan and the Trust. The Abbott
Laboratories Stock Retirement Plan is a qualified profit sharing
plan. As of December 31, 1994, there were 35,431 participants
with share balances in the Plan.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
Not applicable.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
This statement is filed on behalf of each individual listed below pursuant to
their agreement.
FEBRUARY 7, 1995
--------------------------------
Date
/s/ GARY P. COUGHLAN ABBOTT LABORATORIES STOCK
- ----------------------------- RETIREMENT TRUST
Gary P. Coughlan
/s/ THOMAS C. FREYMAN
- -----------------------------
Thomas C. Freyman
/s/ ELLEN M. WALVOORD /s/ THOMAS C. FREYMAN
- ----------------------------- ---------------------------------
Ellen M. Walvoord Thomas C. Freyman, Chairman of
Trustees, Abbott Laboratories
Stock Retirement Trust
Page 7 of 7 pages
<PAGE>
Disclaimer of Beneficial Ownership
under Rule 13d-4
----------------------------------
The filing of Schedule 13G Amendment 16 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned
is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934,
the beneficial owner of any securities covered by the Schedule. Pursuant to
Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect
to any shares listed therein of which he would not otherwise be deemed to be
beneficial owner.
/s/ GARY P. COUGHLAN
----------------------------
Gary P. Coughlan
FEBRUARY 7, 1995
----------------------------
Date
<PAGE>
Disclaimer of Beneficial Ownership
under Rule 13d-4
----------------------------------
The filing of Schedule 13G Amendment 16 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned
is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934,
the beneficial owner of any securities covered by the Schedule. Pursuant to
Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect
to any shares listed therein of which he would not otherwise be deemed to be
beneficial owner.
/s/ THOMAS C. FREYMAN
-----------------------------
Thomas C. Freyman
FEBRUARY 7, 1995
------------------------------
Date
<PAGE>
Disclaimer of Beneficial Ownership
under Rule 13d-4
----------------------------------
The filing of Schedule 13G Amendment 16 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned
is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934,
the beneficial owner of any securities covered by the Schedule. Pursuant to
Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect
to any shares listed therein of which she would not otherwise be deemed to be
beneficial owner.
/s/ ELLEN M. WALVOORD
----------------------------
Ellen M. Walvoord
FEBRUARY 7, 1995
----------------------------
Date
SEC/13G Form